EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Prophylactic Methylprednisolone in Neonatal On-Pump Cardiac Surgery

Peng Gao, Yu Jin, He Wang iD, Peiyao Zhang, Wenting Wang, Jia Liu, Zhengyi Feng, Bingyang Ji, Jinping Liu iD, Jinxiao Hu

Reviews in Cardiovascular Medicine · 26.06.2026 · 27 (6)

DOI: 10.31083/rcm49485 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Reviews in Cardiovascular Medicine, online erschienen am 26.06.2026. Verfasst von Peng Gao und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, 100007 Bei…. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National High Level Hospital Clinical Research Funding, CAMS Innovation Fund for Medical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background:Corticosteroids are commonly used in neonatal cardiac surgery to reduce inflammation. Previous studies have shown that administering methylprednisolone (MP) during the perioperative period can reduce the inflammatory response. However, the impact of MP on postoperative clinical outcomes in neonates remains unclear. Thus, this study aimed to assess the effects of MP on postoperative inflammation and clinical outcomes in neonates undergoing cardiac surgery involving cardiopulmonary bypass (CPB).Methods:This was a prospective, non-randomized, unblinded, controlled trial in which the clinicians determined treatment assignment. A total of 86 neonates who underwent cardiac surgery with CPB between December 2020 and August 2023 were included. After induction of anesthesia, the MP group received a single dose of 30 mg/kg MP, while the placebo group received an equal volume of saline solution. Primary endpoints were plasma interleukin (IL-6, IL-8, and IL-10) and D-dimer concentrations. Composite outcomes included death, respiratory infection, cardiac arrest, need for extracorporeal membrane oxygenation, acute kidney injury, low cardiac output syndrome, and need for prolonged mechanical ventilation.Results:Consistent with the observed anti-inflammatory effects, MP administration was associated with significantly lower levels of proinflammatory cytokines (IL-6, IL-8) and higher levels of the anti-inflammatory cytokine (IL-10). MP did not significantly reduce the likelihood of the composite outcome (p = 0.664), with 25 patients (58.1%) in the MP group and 23 patients (53.5%) in the placebo group experiencing such outcomes. The MP group also showed a significantly lower postoperative vasoactive–inotropic score and higher postoperative procalcitonin levels and nadir mixed venous oxygen saturation during the first 24 hours. No significant differences in postoperative D-dimer, blood glucose, or insulin administration were observed between the two groups.Conclusions:Prophylactic administration of 30 mg/kg MP in neonates undergoing cardiac surgery with CPB did not result in a statistically significant improvement in clinical outcomes compared with placebo. However, this intervention was associated with a reduction in the inflammatory response.The Clinical Trial Registration: ChiCTR 2000040230, https://www.chictr.org.cn/showproj.html?proj=64716.

Schlagwörter

Stichwörter der Autor:innen

cardiac surgerycardiopulmonary bypassclinical outcomecorticosteroidsinflammatory responseneonate

Autor:innen und Institutionen

  • Department of Anesthesiology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, 100007 Beijing, China.
  • Pediatric cardiac center, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, 100037 Beijing, China.
  • Department of Anesthesiology, Beijing Chao-Yang Hospital, Capital Medical University, 100020 Beijing, China.
  • Department of Anesthesiology, Jiangsu Province Hospital, Nanjing Medical University, 210029 Nanjing, Jiangsu, China.

ORCID-Profile: He Wang, Jinping Liu

Förderung

  • National High Level Hospital Clinical Research Funding
  • CAMS Innovation Fund for Medical Sciences

Zitieren

APA

Gao, P., Jin, Y., Wang, H., Zhang, P., Wang, W., Liu, J., Feng, Z., Ji, B., Liu, J., & Hu, J. (2026). Prophylactic Methylprednisolone in Neonatal On-Pump Cardiac Surgery. Reviews in Cardiovascular Medicine, 27(6). https://doi.org/10.31083/rcm49485

Vancouver

Gao P, Jin Y, Wang H, Zhang P, Wang W, Liu J, et al. Prophylactic Methylprednisolone in Neonatal On-Pump Cardiac Surgery. Reviews in Cardiovascular Medicine. 2026;27(6). doi:10.31083/rcm49485

BibTeX
@article{Gao2026,
  author = {Gao, Peng and Jin, Yu and Wang, He and Zhang, Peiyao and Wang, Wenting and Liu, Jia and Feng, Zhengyi and Ji, Bingyang and Liu, Jinping and Hu, Jinxiao},
  title = {Prophylactic Methylprednisolone in Neonatal On-Pump Cardiac Surgery},
  journal = {Reviews in Cardiovascular Medicine},
  year = {2026},
  volume = {27},
  number = {6},
  doi = {10.31083/rcm49485}
}
Kostenlos starten →